Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats

Hongmei Tang, Daxiang Lu, Rui Pan, Xuebin Qin, Huangui Xiong, Jun Dong

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Aims: Human immunodeficiency virus-1 (HIV-1)-associated dementia (HAD) is a significant consequence of HIV infection. Although highly active antiretroviral therapy (HAART) has dramatically decreased HIV-1 load in acquired immune deficiency syndrome (AIDS) patients, HAART does not completely protect against the development of HAD, therefore novel strategies for the prevention and treatment are urgently needed. In this study, we chose curcumin which has a neuroprotective role and tested the effect against neuron damage induced by HIV-1gp120 V3 loop peptide. Main methods: Rats were given 150 ng gp120 V3 peptide by intracerebroventricular (ICV) infusion for 3 days to establish the cognitive dysfunction model. After recovery from the surgery, the rats in treatment groups were given curcumin by intragastric infusion for 2 weeks. Subsequently, we used the Morris water maze test, long-term potentiation (LTP) recording, biochemical measurement of oxidative damage, Nissl staining, and BDNF immunostaining to evaluate the neuropathological changes and the effect of curcumin on rats. Key findings: Our results documented that the gp120 V3 peptide induced impairment of spatial learning and memory, inhibited LTP in the CA1 region of the hippocampus, and mediated oxidative stress and neuronal injury. These impairments were ameliorated by intragastric infusion of curcumin. Significance: These results suggested that dietary supplementation of curcumin may be a potential therapeutic strategy for the treatment and/or prevention of HAD.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalLife Sciences
Volume85
Issue number1-2
DOIs
StatePublished - Jul 1 2009

Fingerprint

Curcumin
Viruses
HIV-1
Rats
Glycoproteins
Data storage equipment
Peptides
Dementia
Long-Term Potentiation
Highly Active Antiretroviral Therapy
Intraventricular Infusions
Oxidative stress
Brain-Derived Neurotrophic Factor
Therapeutics
Dietary Supplements
Surgery
Neurons
HIV Infections
Hippocampus
Acquired Immunodeficiency Syndrome

Keywords

  • Curcumin
  • HAD
  • HIV-1gp120
  • Neuroprotection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. / Tang, Hongmei; Lu, Daxiang; Pan, Rui; Qin, Xuebin; Xiong, Huangui; Dong, Jun.

In: Life Sciences, Vol. 85, No. 1-2, 01.07.2009, p. 1-10.

Research output: Contribution to journalArticle

Tang, Hongmei ; Lu, Daxiang ; Pan, Rui ; Qin, Xuebin ; Xiong, Huangui ; Dong, Jun. / Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. In: Life Sciences. 2009 ; Vol. 85, No. 1-2. pp. 1-10.
@article{766da184f0b842959df8519eba197d80,
title = "Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats",
abstract = "Aims: Human immunodeficiency virus-1 (HIV-1)-associated dementia (HAD) is a significant consequence of HIV infection. Although highly active antiretroviral therapy (HAART) has dramatically decreased HIV-1 load in acquired immune deficiency syndrome (AIDS) patients, HAART does not completely protect against the development of HAD, therefore novel strategies for the prevention and treatment are urgently needed. In this study, we chose curcumin which has a neuroprotective role and tested the effect against neuron damage induced by HIV-1gp120 V3 loop peptide. Main methods: Rats were given 150 ng gp120 V3 peptide by intracerebroventricular (ICV) infusion for 3 days to establish the cognitive dysfunction model. After recovery from the surgery, the rats in treatment groups were given curcumin by intragastric infusion for 2 weeks. Subsequently, we used the Morris water maze test, long-term potentiation (LTP) recording, biochemical measurement of oxidative damage, Nissl staining, and BDNF immunostaining to evaluate the neuropathological changes and the effect of curcumin on rats. Key findings: Our results documented that the gp120 V3 peptide induced impairment of spatial learning and memory, inhibited LTP in the CA1 region of the hippocampus, and mediated oxidative stress and neuronal injury. These impairments were ameliorated by intragastric infusion of curcumin. Significance: These results suggested that dietary supplementation of curcumin may be a potential therapeutic strategy for the treatment and/or prevention of HAD.",
keywords = "Curcumin, HAD, HIV-1gp120, Neuroprotection",
author = "Hongmei Tang and Daxiang Lu and Rui Pan and Xuebin Qin and Huangui Xiong and Jun Dong",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.lfs.2009.03.013",
language = "English (US)",
volume = "85",
pages = "1--10",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "1-2",

}

TY - JOUR

T1 - Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats

AU - Tang, Hongmei

AU - Lu, Daxiang

AU - Pan, Rui

AU - Qin, Xuebin

AU - Xiong, Huangui

AU - Dong, Jun

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Aims: Human immunodeficiency virus-1 (HIV-1)-associated dementia (HAD) is a significant consequence of HIV infection. Although highly active antiretroviral therapy (HAART) has dramatically decreased HIV-1 load in acquired immune deficiency syndrome (AIDS) patients, HAART does not completely protect against the development of HAD, therefore novel strategies for the prevention and treatment are urgently needed. In this study, we chose curcumin which has a neuroprotective role and tested the effect against neuron damage induced by HIV-1gp120 V3 loop peptide. Main methods: Rats were given 150 ng gp120 V3 peptide by intracerebroventricular (ICV) infusion for 3 days to establish the cognitive dysfunction model. After recovery from the surgery, the rats in treatment groups were given curcumin by intragastric infusion for 2 weeks. Subsequently, we used the Morris water maze test, long-term potentiation (LTP) recording, biochemical measurement of oxidative damage, Nissl staining, and BDNF immunostaining to evaluate the neuropathological changes and the effect of curcumin on rats. Key findings: Our results documented that the gp120 V3 peptide induced impairment of spatial learning and memory, inhibited LTP in the CA1 region of the hippocampus, and mediated oxidative stress and neuronal injury. These impairments were ameliorated by intragastric infusion of curcumin. Significance: These results suggested that dietary supplementation of curcumin may be a potential therapeutic strategy for the treatment and/or prevention of HAD.

AB - Aims: Human immunodeficiency virus-1 (HIV-1)-associated dementia (HAD) is a significant consequence of HIV infection. Although highly active antiretroviral therapy (HAART) has dramatically decreased HIV-1 load in acquired immune deficiency syndrome (AIDS) patients, HAART does not completely protect against the development of HAD, therefore novel strategies for the prevention and treatment are urgently needed. In this study, we chose curcumin which has a neuroprotective role and tested the effect against neuron damage induced by HIV-1gp120 V3 loop peptide. Main methods: Rats were given 150 ng gp120 V3 peptide by intracerebroventricular (ICV) infusion for 3 days to establish the cognitive dysfunction model. After recovery from the surgery, the rats in treatment groups were given curcumin by intragastric infusion for 2 weeks. Subsequently, we used the Morris water maze test, long-term potentiation (LTP) recording, biochemical measurement of oxidative damage, Nissl staining, and BDNF immunostaining to evaluate the neuropathological changes and the effect of curcumin on rats. Key findings: Our results documented that the gp120 V3 peptide induced impairment of spatial learning and memory, inhibited LTP in the CA1 region of the hippocampus, and mediated oxidative stress and neuronal injury. These impairments were ameliorated by intragastric infusion of curcumin. Significance: These results suggested that dietary supplementation of curcumin may be a potential therapeutic strategy for the treatment and/or prevention of HAD.

KW - Curcumin

KW - HAD

KW - HIV-1gp120

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=67349222186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349222186&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2009.03.013

DO - 10.1016/j.lfs.2009.03.013

M3 - Article

C2 - 19345695

AN - SCOPUS:67349222186

VL - 85

SP - 1

EP - 10

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 1-2

ER -